대한천식알레르기학회 설하면역요법 진료지침

키워드

참고문헌 (58)

1. Jutel M, "International consensus on allergy immunotherapy", J Allergy Clin Immunol, 136, pp.556~568 (2015)
2. Noon L, "Prophylactic inoculation against hay fever", Lancet, 177, pp.1572~1573 (1911)
3. Freeman J, "Further observations on the treatment of hay fever by hypodermic inoculations of pollen vaccine. Historical document", Ann Allergy, 18, pp.427~434 (1960)
4. Hur GY, "Allergy immunotherapy", Korean J Asthma Allergy Clin Immunol, 30, pp.153~183 (2010)
5. Balshem H, "GRADE guidelines: 3. Rating the quality of evidence", J Clin Epidemiol, 64, pp.401~406 (2011)
6. Lawrence MG, "Basic science for the clinician : mechanisms of sublingual and subcutaneous immunotherapy", Ann Allergy Asthma Immunol, 117, pp.138~142 (2016)
7. Ozdemir C, "Mechanisms of aeroallergen immunotherapy : subcutaneous immunotherapy and sublingual immunotherapy", Immunol Allergy Clin North Am, 36, pp.71~86 (2016)
8. Mascarell L, "Oral dendritic cells mediate antigen-specific tolerance by stimulating TH1 and regulatory CD4+ T cells", J Allergy Clin Immunol, 122, pp.603~609 (2008)
9. Mascarell L, "Oral macrophage-like cells play a key role in tolerance induction following sublingual immunotherapy of asthmatic mice", Mucosal Immunol, 4, pp.638~647 (2011)
10. Allam JP, "Characterization of dendritic cells from human oral mucosa : a new Langerhans’ cell type with high constitutive FcepsilonRI expression", J Allergy Clin Immunol, 112, pp.141~148 (2003)
11. Didier A, "Optimal dose, efficacy, and safety of once-daily sublingual immunotherapy with a 5-grass pollen tablet for seasonal allergic rhinitis", J Allergy Clin Immunol, 120, pp.1338~1345 (2007)
12. Bergmann KC, "Efficacy and safety of sublingual tablets of house dust mite allergen extracts in adults with allergic rhinitis", J Allergy Clin Immunol, 133, pp.1608~1614 (2014)
13. Roberts G, "EAACI guidelines on allergen immunotherapy : allergic rhinoconjunctivitis", Allergy, 73, pp.765~798 (2018)
14. Pfaar O, "Guideline on allergen-specific immunotherapy in IgE-mediated allergic diseases : S2k Guideline of the German Society for Allergology and Clinical Immunology(DGAKI), the Society for Pediatric Allergy and Environmental Medicine(GPA), the Medical Association of German Allergologists(AeDA), the Austrian Society for Allergy and Immunology(ÖGAI), the Swiss Society for Allergy and Immunology(SGAI), the German Society of Dermatology(DDG), the German Society of Oto-Rhino-Laryngology, Head and Neck Surgery(DGHNO-KHC), the German Society of Pediatrics and Adolescent Medicine(DGKJ), the Society for Pediatric Pneumology(GPP), the German Respiratory Society(DGP), the German Association of ENT Surgeons(BV-HNO), the Professional Federation of Paediatricians and Youth Doctors(BVKJ), the Federal Association of Pulmonologists(BDP)and the German Dermatologists Association(BVDD)", Allergo J Int, 23, pp.282~319 (2014)
15. Brozek JL, "Allergic Rhinitis and its Impact on Asthma(ARIA)guidelines : 2010 revision", J Allergy Clin Immunol, 126, pp.466~476 (2010)
16. Canonica GW, "Sublingual immunotherapy : World Allergy Organization position paper 2013 update", World Allergy Organ J, 7, pp.6~ (2014)
17. Korean Rhinologic Society, "Allergic rhinitis update" (2022), Korean Rhinologic Society
18. Korean Academy of Asthma, "Allergy and Clinical Immunology. Korean guidelines for allergic rhinitis", Korean Academy of Asthma, Allergy and Clinical Immunology, ~ (2015)
19. Guez S, "House-dust-mite sublingual-swallow immunotherapy(SLIT)in perennial rhinitis : a double-blind, placebo-controlled study", Allergy, 55, pp.369~375 (2000)
20. Hirsch T, "Double-blind placebo-controlled study of sublingual immunotherapy with house dust mite extract (D.pt.) in children", Pediatr Allergy Immunol, 8, pp.21~27 (1997)
21. Marogna M, "Effects of sublingual immunotherapy for multiple or single allergens in polysensitized patients", Ann Allergy Asthma Immunol, 98, pp.274~280 (2007)
22. Nolte H, "Efficacy of house dust mite sublingual immunotherapy tablet in North American adolescents and adults in a randomized, placebo-controlled trial", J Allergy Clin Immunol, 138, pp.1631~1638 (2016)
23. Amar SM, "Response to sublingual immunotherapy with grass pollen extract : monotherapy versus combination in a multiallergen extract", J Allergy Clin Immunol, 124, pp.150~156 (2009)
24. Radulovic S, "Sublingual immunotherapy for allergic rhinitis", Cochrane Database Syst Rev, 2010, pp.CD002893~ (2010)
25. Wise SK, "International consensus statement on allergy and rhinology : allergic rhinitis", Int Forum Allergy Rhinol, 8, pp.108~352 (2018)
26. Radulovic S, "Systematic reviews of sublingual immunotherapy(SLIT)", Allergy, 66, pp.740~752 (2011)
27. Durham SR, "Treatment effect of sublingual immunotherapy tablets and pharmacotherapies for seasonal and perennial allergic rhinitis : pooled analyses", J Allergy Clin Immunol, 138, pp.1081~1088 (2016)
28. Xian M, "Changes in CD4+CD25+FoxP3+ regulatory T cells and serum cytokines in sublingual and subcutaneous immunotherapy in allergic rhinitis with or without asthma", Int Arch Allergy Immunol, 181, pp.71~80 (2020)
29. Tahamiler R, "Comparison of the long-term efficacy of subcutaneous and sublingual immunotherapies in perennial rhinitis", ORL J Otorhinolaryngol Relat Spec, 70, pp.144~150 (2008)
30. Kim JY, "Efficacy of subcutaneous and sublingual immunotherapy for house dust mite allergy : a network meta-analysis-based comparison", J Allergy Clin Immunol Pract, 9, pp.4450~4458 (2021)
31. Nelson H, "Network meta-analysis shows commercialized subcutaneous and sublingual grass products have comparable efficacy", J Allergy Clin Immunol Pract, 3, pp.256~266 (2015)
32. Pfaar O, "Recommendations for the standardization of clinical outcomes used in allergen immunotherapy trials for allergic rhinoconjunctivitis : an EAACI Position Paper", Allergy, 69, pp.854~867 (2014)
33. Bousquet J, "Assessment of quality of life in patients with perennial allergic rhinitis with the French version of the SF-36 Health Status Questionnaire", J Allergy Clin Immunol, 94, pp.182~188 (1994)
34. Juniper EF, "Development and testing of a new measure of health status for clinical trials in rhinoconjunctivitis", Clin Exp Allergy, 21, pp.77~83 (1991)
35. Laforest L, "Quality of life during pollen season in patients with seasonal allergic rhinitis with or without asthma", Int Arch Allergy Immunol, 136, pp.281~286 (2005)
36. Barker-Tejeda TC, "Exploring novel systemic biomarker approaches in grass-pollen sublingual immunotherapy using omics", Allergy, 76, pp.1199~1212 (2021)
37. Heeringa JJ, "Induction of IgG(2)and IgG(4)B-cell memory following sublingual immunotherapy for ryegrass pollen allergy", Allergy, 75, pp.1121~1132 (2020)
38. Di Lorenzo G, "Evaluation of serum s-IgE", total IgE ratio in predicting clinical response to allergen-specific immunotherapy, 2009, pp.123, 1103~1110
39. Calderón MA, "European Survey on Adverse Systemic Reactions in Allergen Immunotherapy(EASSI) : a real-life clinical assessment", Allergy, 72, pp.462~472 (2017)
40. Rodríguez Del Río P, "The European Survey on Adverse Systemic Reactions in Allergen Immunotherapy(EASSI) : a paediatric assessment", Pediatr Allergy Immunol, 28, pp.60~70 (2017)
41. Calderón MA, "Sublingual allergen immunotherapy : mode of action and its relationship with the safety profile", Allergy, 67, pp.302~311 (2012)
42. Greenhawt M, "Sublingual immunotherapy : a focused allergen immunotherapy practice parameter update", Ann Allergy Asthma Immunol, 118, pp.276~282 (2017)
43. Blaiss M, "Efficacy and safety of timothy grass allergy immunotherapy tablets in North American children and adolescents", J Allergy Clin Immunol, 127, pp.64~71 (2011)
44. Dahl R, "Specific immunotherapy with SQ standardized grass allergen tablets in asthmatics with rhinoconjunctivitis", Allergy, 61, pp.185~190 (2006)
45. Mosbech H, "Standardized quality(SQ)house dust mite sublingual immunotherapy tablet(ALK)reduces inhaled corticosteroid use while maintaining asthma control : a randomized, double-blind, placebo-controlled trial", J Allergy Clin Immunol, 134, pp.568~575 (2014)
46. Didier A, "Prolonged efficacy of the 300IR 5-grass pollen tablet up to 2 years after treatment cessation, as measured by a recommended daily combined score", Clin Transl Allergy, 5, pp.12~ (2015)
47. Durham SR, "Long-term clinical efficacy in grass pollen-induced rhinoconjunctivitis after treatment with SQ-standardized grass allergy immunotherapy tablet", J Allergy Clin Immunol, 125, pp.131~138 (2010)
48. Durham SR, "SQ-standardized sublingual grass immunotherapy : confirmation of disease modification 2 years after 3 years of treatment in a randomized trial", J Allergy Clin Immunol, 129, pp.717~725 (2012)
49. Valovirta E, "Results from the 5-year SQ grass sublingual immunotherapy tablet asthma prevention(GAP)trial in children with grass pollen allergy", J Allergy Clin Immunol, 141, pp.529~538 (2018)
50. Okubo K, "Efficacy and safety of the SQ house dust mite sublingual immunotherapy tablet in Japanese adults and adolescents with house dust mite-induced allergic rhinitis", J Allergy Clin Immunol, 139, pp.1840~1848 (2017)
51. Lin Z, "The effects of house dust mite sublingual immunotherapy in patients with allergic rhinitis according to duration", Int Forum Allergy Rhinol, 6, pp.82~87 (2016)
52. Cox L, "Allergen immunotherapy : a practice parameter third update", J Allergy Clin Immunol, 127(1 Suppl), pp.S1~S55 (2011)
53. Marogna M, "Preventive effects of sublingual immunotherapy in childhood : an open randomized controlled study", Ann Allergy Asthma Immunol, 101, pp.206~211 (2008)
54. Novembre E, "Coseasonal sublingual immunotherapy reduces the development of asthma in children with allergic rhinoconjunctivitis", J Allergy Clin Immunol, 114, pp.851~857 (2004)
55. Marogna M, "Long-lasting effects of sublingual immunotherapy according to its duration : a 15-year prospective study", J Allergy Clin Immunol, 126, pp.969~975 (2010)
56. Passalacqua G, "30 years of sublingual immunotherapy", Allergy, 75, pp.1107~1120 (2020)
57. Didier A, "Post-treatment efficacy of discontinuous treatment with 300IR 5-grass pollen sublingual tablet in adults with grass pollen-induced allergic rhinoconjunctivitis", Clin Exp Allergy, 43, pp.568~577 (2013)
58. Lee HY, "KAAACI guidelines for allergen immunotherapy", Allergy Asthma Immunol Res, 15, pp.725~756 (2023)

관련 논문AI추천